M&A Deal Summary

Mahana Therapeutics Acquires Cara Care

On March 12, 2024, Mahana Therapeutics acquired consumer services company Cara Care

Acquisition Highlights
  • This is Mahana Therapeutics’ 1st transaction in the Consumer Services sector.
  • This is Mahana Therapeutics’ 1st transaction in Germany.

M&A Deal Summary
Date 2024-03-12
Target Cara Care
Sector Consumer Services
Buyer(s) Mahana Therapeutics
Deal Type Add-on Acquisition

Target

Cara Care

Berlin, Germany
Cara Care is a digital therapeutic app for digestive diseases, which spans medication management as well as dietary and mental health interventions to improve gastrointestinal health.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Mahana Therapeutics

San Francisco, California, United States
Category Company
Founded 2018
Sector Consumer Services
DESCRIPTION

Mahana Therapeutics is a developer of digital chronic condition management programs designed to empower patients with chronic conditions to live fuller lives. The company’s first product, Mahana IBS, was the first digital therapeutic to receive FDA clearance for the treatment of IBS and provides cognitive behavioral therapy (CBT) to adults with IBS. Mahana Therapeutics was founded in 2018 and is based in San Francisco, California.

DEAL STATS #
Overall 1 of 1
Sector (Consumer Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal